Sara Kate Dann, PA

Sara Dann practices at Buffalo Surgery Center LLC in Buffalo, New York.

Sara Dann's NPI, 1992946834, was assigned on March 23, 2009. Sara Dann holds New York license 013233.

Sara Dann's primary practice is Buffalo Surgery Center LLC, at 3925 Sheridan Dr, Buffalo, NY 14226 in Erie County. The practice phone is (716) 250-6520.

Sara Dann's primary practice is Buffalo Surgery Center LLC in Buffalo, New York. Sara Dann is also affiliated with Kenmore Mercy Hospital. The medical group on file is Mercy Hospital of Buffalo. Dmand AI also links Sara Dann to 4 more medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sara Dann practices, 4 sites in all. Vendor and product names are available with a free account.

Physician assistant is Sara Dann's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Sara Dann is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Sara Dann is licensed in New York.

Dmand AI lists arthritis, broken or dislocated ankle/ or foot, enthesopathy in foot or ankle, minor injury to a limb, rotator cuff injury and traumatic arthropathy among the conditions Sara Dann treats.

CMS data shows 1,020 Medicare services from Sara Dann across 11 procedure codes in 2024, for 182 Medicare patients. Medicare paid $27,735 for them. Every service was in an office.

CMS counts 182 Medicare patients who saw Sara Dann in 2024. The largest group is 65 to 74, with 75 patients. 75% of them have arthritis, and 75% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Sara Dann's median patient age at 64, with 63% women.

In 2024, Sara Dann wrote 281 Medicare Part D claims for 204 patients. 100% of them were for generic drugs. CMS names the drug for 233 of them, across 5 drugs with 11 or more claims each, at $1,700 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Sara Dann for performance year 2024, reported as part of a group. Sara Dann accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 2 general payments to Sara Dann from 2 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbott Laboratories paid the most, $24.